↓ Skip to main content

Dove Medical Press

Article Metrics

Review of the safety, efficacy, and side effect profile of asenapine in the treatment of bipolar 1 disorder

Overview of attention for article published in Patient preference and adherence, July 2011
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (73rd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

twitter
2 tweeters
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
21 Dimensions

Readers on

mendeley
61 Mendeley
Title
Review of the safety, efficacy, and side effect profile of asenapine in the treatment of bipolar 1 disorder
Published in
Patient preference and adherence, July 2011
DOI 10.2147/ppa.s10968
Pubmed ID
Authors

Jodi Gonzalez, Thompson, Troy Moore

Abstract

Asenapine is approved for acute manic and mixed states in bipolar disorder. The objective is to review the efficacy of asenapine in bipolar disorder, with a particular focus on acceptability and adherence to treatment.

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 61 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Canada 2 3%
Spain 1 2%
Unknown 58 95%

Demographic breakdown

Readers by professional status Count As %
Researcher 18 30%
Student > Bachelor 8 13%
Other 8 13%
Student > Postgraduate 7 11%
Student > Ph. D. Student 4 7%
Other 10 16%
Unknown 6 10%
Readers by discipline Count As %
Medicine and Dentistry 29 48%
Agricultural and Biological Sciences 3 5%
Psychology 3 5%
Pharmacology, Toxicology and Pharmaceutical Science 3 5%
Biochemistry, Genetics and Molecular Biology 2 3%
Other 14 23%
Unknown 7 11%

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 December 2013.
All research outputs
#5,461,432
of 19,943,904 outputs
Outputs from Patient preference and adherence
#360
of 1,431 outputs
Outputs of similar age
#44,291
of 172,698 outputs
Outputs of similar age from Patient preference and adherence
#9
of 20 outputs
Altmetric has tracked 19,943,904 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 1,431 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.0. This one has gotten more attention than average, scoring higher than 73% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 172,698 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.
We're also able to compare this research output to 20 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.